Abstract
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive procedure whereby a pulsed magnetic field stimulates electrical activity in the brain. Parkinson's disease (PD) is a neurodegenerative process characterized by numerous motor and nonmotor clinical manifestations for which effective, mechanism-based treatments remain elusive. Consequently, more advanced non-invasive therapeutic methods are required. A possible method of rehabilitation that may be effective and potentially viable for use in clinical practice is rTMS. Here, we focus on the basic foundation of rTMS, the main findings of rTMS from animal models, the effects of rTMS on sensorimotor integration in patients with PD, and the experimental advances of rTMS that may become a viable clinical application to treat the disease.
Keywords: rTMS, Parkinsons disease, cellular and molecular mechanisms, Neurorehabilitation, Sensorimotor integration, Deep brain stimulation, HPLC, Prefrontal cortex, L-DOPA, iTBS
CNS & Neurological Disorders - Drug Targets
Title: Is rTMS an Effective Therapeutic Strategy that Can Be Used to Treat Parkinson's Disease?
Volume: 10 Issue: 6
Author(s): Oscar Arias-Carrion, Sergio Machado, Flavia Paes, Bruna Velasques, Silmar Teixeira, Lizbeth Cardenas-Morales, Roberto Piedade, Pedro Ribeiro and Antonio E. Nardi
Affiliation:
Keywords: rTMS, Parkinsons disease, cellular and molecular mechanisms, Neurorehabilitation, Sensorimotor integration, Deep brain stimulation, HPLC, Prefrontal cortex, L-DOPA, iTBS
Abstract: Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive procedure whereby a pulsed magnetic field stimulates electrical activity in the brain. Parkinson's disease (PD) is a neurodegenerative process characterized by numerous motor and nonmotor clinical manifestations for which effective, mechanism-based treatments remain elusive. Consequently, more advanced non-invasive therapeutic methods are required. A possible method of rehabilitation that may be effective and potentially viable for use in clinical practice is rTMS. Here, we focus on the basic foundation of rTMS, the main findings of rTMS from animal models, the effects of rTMS on sensorimotor integration in patients with PD, and the experimental advances of rTMS that may become a viable clinical application to treat the disease.
Export Options
About this article
Cite this article as:
Arias-Carrion Oscar, Machado Sergio, Paes Flavia, Velasques Bruna, Teixeira Silmar, Cardenas-Morales Lizbeth, Piedade Roberto, Ribeiro Pedro and E. Nardi Antonio, Is rTMS an Effective Therapeutic Strategy that Can Be Used to Treat Parkinson's Disease?, CNS & Neurological Disorders - Drug Targets 2011; 10 (6) . https://dx.doi.org/10.2174/187152711797247821
DOI https://dx.doi.org/10.2174/187152711797247821 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biofilms: An Extra Hurdle for Effective Antimicrobial Therapy
Current Pharmaceutical Design Current and Future Neuropharmacological Options for the Treatment of Essential Tremor
Current Neuropharmacology Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
Current Drug Metabolism RNA Interference and Amyotrophic Lateral Sclerosis
Current Drug Metabolism subject Index To Volume 1
Current Drug Targets - CNS & Neurological Disorders Cardiovascular Risk, Inflammation and Physical Activity in Rheumatoid Arthritis
Current Rheumatology Reviews Recent Approaches for Studying the Role of Glia
CNS & Neurological Disorders - Drug Targets Genetic Aspects of Lone Atrial Fibrillation: What Do We Know?
Current Pharmaceutical Design Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases
Current Immunology Reviews (Discontinued) Neuroinflammation and Behavioral Deficit in Rotenone-Induced Neurotoxicity in Rats and the Possible Effects of Butanolic Extract of <i>Centaurea africana</i>
Recent Advances in Inflammation & Allergy Drug Discovery The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments
Current Neuropharmacology Shining Light on an mGlu5 Photoswitchable NAM: A Theoretical Perspective
Current Neuropharmacology Engineering of Nanoemulsions for Drug Delivery
Current Drug Delivery Towards Drug Discovery for Brain Tumours: Interaction of Kinins and Tumours at the Blood Brain Barrier Interface
Recent Patents on CNS Drug Discovery (Discontinued) Insights into Airway Infections by Enterococci: A Review
Recent Patents on Anti-Infective Drug Discovery Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Surgical Management of Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
Current Pharmaceutical Design Nanotechnology Driven Approaches for the Management of Parkinson’s Disease: Current Status and Future Perspectives
Current Drug Metabolism GEMSP: A New Therapeutic Approach to Multiple Sclerosis
Central Nervous System Agents in Medicinal Chemistry